The attraction of chemokines as a target for specific anti‐inflammatory therapy
- 1 January 2006
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 147 (S1) , S212-S221
- https://doi.org/10.1038/sj.bjp.0706475
Abstract
Since the identification of the first chemotactic cytokines 20 years ago, the field has mushroomed, with the discovery of approximately 40 ligands, which interact with 20 different cell surface receptors. At the time of writing this review, a PubMed trawl using the word 'chemokine' will recover over 28,000 manuscripts. In this article, we will give a short history of the discovery of chemokines and provide examples of the potential for therapeutic targeting of the chemokine network in inflammatory disease.Keywords
This publication has 48 references indexed in Scilit:
- Chemokine receptor internalization and intracellular traffickingCytokine & Growth Factor Reviews, 2005
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005
- GPCR dimerisationLife Sciences, 2003
- Eotaxin and asthmaCurrent Opinion in Pharmacology, 2001
- Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal TransductionScience, 2000
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 ReceptorScience, 1991
- Structure and Functional Expression of a Human Interleukin-8 ReceptorScience, 1991
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Novel neutrophil-stimulating peptidesImmunology Today, 1989